←
Joseph Varon5,111 posts
Joseph Varon avatar

Joseph Varon

@joevaron
◷ Joined April 2009▧ 472 Photos and videos
Independent Medical Alliance avatar
⟳ Joseph Varon retweeted
Independent Medical Alliance@Honest_Medicine·2h

New Journal of Independent Medicine Issue: Challenging Old Assumptions and Rethinking Medicine 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘰𝘧 𝘐𝘯𝘥𝘦𝘱𝘦𝘯𝘥𝘦𝘯𝘵 𝘔𝘦𝘥𝘪𝘤𝘪𝘯𝘦 (@JIndepMed) Editor-in-Chief Dr. Joseph Varon (@joevaron) and Assistant Editor-in-Chief Dr. Adylle Varon introduce the latest issue, highlighting new research and perspectives on pediatric vaccination, vaccine injury recognition, influenza treatment, repurposed treatments, and the importance of questioning established medical assumptions. Watch now. Explore the latest issue of the Journal - link below. 🔽

4:43

Journal of Independent Medicine Closes 2026 by Challenging Old Assumptions and Rethinking How We Treat the Whole Patient Tenth issue examines emerging evidence, repurposed treatments, patient autonomy and the scientific humility required to move medicine forward FULL STATEMENT: Washington, D.C. — (November 18, 2026) The Independent Medical Alliance (IMA) today announced the publication of Volume 2, Issue 6 of the Journal of Independent Medicine (JIM), marking the journal’s tenth issue to date and closing its second year with research and perspectives that challenge established assumptions, revisit familiar treatments and emphasize a more individualized approach to patient care. The new issue brings together editorials, reviews, original research and perspectives spanning influenza treatment, medical reversals, metabolic health, pediatric vaccine policy, stroke therapy, healthcare access, informed consent and vaccine-injury research. A common theme runs throughout the issue: medicine advances not by defending what has always been done, but by continually testing assumptions against new evidence and asking whether existing approaches are truly serving the individual patient. That principle is captured directly in Editor-in-Chief of the Journal of Independent Medicine (@JIndepMed) Joseph Varon, MD's (@joevaron) editorial, “When Medicine Refuses to Admit It Was Wrong,” which examines why ineffective or outdated medical practices can persist even as evidence evolves—and argues that scientific humility and a willingness to correct course are essential to progress. “The history of medicine is filled with ideas that were once considered settled and later had to be reconsidered,” said Dr. Varon, President and Chief Medical Officer of IMA. “That is not a failure of science; the failure comes when medicine stops questioning itself. Our responsibility as physicians is to follow the evidence, remain willing to rethink what we believe we know, and treat the person in front of us—not simply a diagnosis, protocol or institutional standard. Independent thinking, informed consent and the doctor-patient relationship must remain at the heart of good medicine.” The theme is echoed in Dr. Paul Marik’s (@drpaulmarik1) “Treat the Patient, Not Just the Virus: Rethinking Influenza Treatment,” which examines influenza care beyond antiviral therapy alone and considers a broader framework incorporating inflammation, immune response, supportive care and potential adjunctive treatments. The issue also includes a systematic review of minocycline as a repurposed therapy for acute stroke, an original study examining a paleolithic ketogenic diet and metabolic outcomes, research into socioeconomic differences in access to advanced cardiac resuscitation, and perspectives on informed consent and the recognition and study of suspected vaccine-related injuries. Looking Back at 250 Years as well as Forward The issue arrives as IMA concludes its year-long reflection on 250 years of American medicine—a project examining both the extraordinary achievements of medical science and the foundational principles that should guide its next chapter. At America’s 250-year mark, IMA has emphasized the importance of restoring many of medicine’s enduring roots: independent clinical judgment, scientific curiosity, informed consent, individualized treatment and a strong relationship between physician and patient. “As we reflect on 250 years of American medicine, one of the most important lessons is that progress has always depended on physicians willing to observe carefully, think independently and reconsider accepted wisdom when the evidence demanded it,” Varon added. “Modern medicine has extraordinary tools, but those tools are most powerful when paired with the fundamentals of doctoring: listening to patients, understanding the whole person, exercising clinical judgment and remaining humble enough to keep asking questions. That is the kind of medicine this Journal exists to advance.” Featured Articles in Volume 2, Issue 6 Treat the Patient, Not Just the Virus: Rethinking Influenza Treatment Paul E. Marik | Editorial Challenges conventional influenza treatment strategies and examines a broader, individualized approach incorporating early intervention, supportive care, immune and inflammatory responses, and potential adjunctive and repurposed therapies. When Medicine Refuses to Admit It Was Wrong Joseph Varon | Editorial Explores why outdated or ineffective practices can persist in medicine and argues that scientific humility, rigorous reassessment and a willingness to correct course are essential to improving patient care. Urogynecology, Urology, and Coloproctology: Historical Development, Shared Pelvic Floor Disorders, and Competency-Based Surgical Limits Francisco Javier Castro-Apodaca et al. | Review Examines overlapping pelvic-floor disorders and surgical responsibilities across three specialties, proposing a competency-based framework that prioritizes documented expertise, collaboration and patient-centered care. Historical, Legal and Scientific Issues of Paediatric Vaccine Mandates Paolo Bellavite; Alberto Donzelli; Eugenio Serravalle | Review Reviews the historical, scientific and legal foundations of childhood vaccine mandates, with particular attention to Italy, and argues for disease-specific evaluation, transparent evidence review and informed consent. The Effect of the Paleolithic Ketogenic Diet (PKD) on Metabolic Parameters, Fatigue, and Sleep Zsófia Clemens et al. | Original Article A retrospective study of 274 adults reports short-term improvements in metabolic measures, fatigue and sleep during a medically supervised paleolithic ketogenic diet program, while calling for longer-term controlled research. Health Correlates of Vaccination: Lessons from Florida’s Medicaid Data Josh Mitteldorf; Brian Hooker | Original Article Examines associations between vaccination histories and selected health diagnoses among 14,235 children in Florida Medicaid data; because the study is observational, the reported correlations do not establish causation. Social and Structural Correlates of ECPR Utilization After Cardiac Arrest in the United States Francesca Martinez-Nachon; Michelle G. Ortiz | Original Article Analyzes more than 243,000 hospitalizations to explore how insurance, income, geography and other structural factors are associated with access to extracorporeal cardiopulmonary resuscitation after cardiac arrest. Platform Medicine and Patient Autonomy: A Socio-Epistemological Analysis of Taxonomic Shifts and Informed Consent in mRNA Deployments Dietmar Kabelka | Perspective Examines how terminology, regulatory classification and scientific uncertainty surrounding mRNA technologies may affect patient understanding and argues for more transparent, platform-specific approaches to informed consent. Vaccine Injury: Recognition, Research and Re-establishing Trust Elizabeth Mumper; Lawrence B. Palevsky; Suzanne K. Gazda Draws on physician perspectives and patient testimony to examine challenges in recognizing and studying suspected vaccine-related injuries and calls for stronger surveillance, research, diagnostic frameworks and multidisciplinary care. Minocycline for Acute Stroke: A Systematic Review of Clinical Efficacy, Safety, and Translational Context Adela Bazbaz; Joseph Varon | Repurposed Drugs Reviews clinical evidence for repurposing the antibiotic minocycline as an adjunctive acute stroke therapy, finding signals of modest functional benefit that warrant continued investigation before broader clinical adoption. Volume 2, Issue 6 and previous issues of the Journal of Independent Medicine are available free of charge online - link below. 🔽

Post attachment
Independent Medical Alliance avatar
⟳ Joseph Varon retweeted
Independent Medical Alliance@Honest_Medicine·21m

Full Disclosure Could Clear Most Drug Ads Off TV and Give Diet and Exercise a Fair Hearing FULL STATEMENT: Washington, D.C. – Drugmakers spent $220 million on TV ads in 1996, the last time drug companies had to disclose a drug's full risks in every broadcast ad. By 2000, three years after the FDA relaxed the requirement, TV spending had reached $1.6 billion, a sevenfold increase, according to research published in the New England Journal of Medicine (@NEJM). Today that number is over $10 billion. That history is why a proposed @FDA rule expected in December should sharply reduce television drug advertising, according to the Independent Medical Alliance (IMA), the nation’s largest coalition of independent physicians, researchers and clinicians. Pharmaceutical industry attorneys have also warned that full on-air disclosure will make many 30- and 60-second spots too long and too costly to run. "Uncontrolled marketing of prescription drugs has given Americans the false impression that a pill is a better choice than exercise, good diet and healthy lifestyle," said IMA President and Chief Medical Officer Dr. Joseph Varon (@joevaron). "Full disclosure gives patients the whole story, and it gives physicians a greater opportunity for a conversation that actually prevents disease." Drugmakers spent $5.96 billion on national TV advertising in 2025, up 16 percent from 2024, according to iSpot.tv. Cornell University researchers found that nearly two-thirds of TV drug ads gave no information about behavioral alternatives to medication, and many directly downplayed the value of diet and exercise. Meanwhile, chronic disease has become more common, and shows up earlier. In 2023, 76.4 percent of U.S. adults reported at least one chronic condition, up from 72.3 percent in 2013. Among adults ages 18 to 34, the share rose from 52.5 percent to 59.5 percent, according to the CDC. A 2023 study in the journal Demography estimated that a girl born in 2019 can expect to spend 58 percent of her life taking prescription drugs, and a boy 47 percent. The public appears ready for the change. In a September 2026 MedShadow Foundation and Siena Research Institute poll, 83 percent of Americans favored limiting prescription drug ads on television and streaming, and half supported banning them outright. "This change is long overdue," said Dr. Varon. "We've marketed American families into an unhealthy dependence on prescription drugs, and the biggest beneficiaries have been the companies selling them. When patients hear the full risks, they ask better questions. That's informed consent working the way it should."

Post attachment
Independent Medical Alliance avatar
⟳ Joseph Varon retweeted
Independent Medical Alliance@Honest_Medicine·Nov 17

A Big Change is Coming: FDA Moves to Rewrite the 1997 Rule That Put Drug Ads on Television Consumer drug advertising grew from $791 million to more than $10 billion after the change. Prescription drug use rose alongside it. FULL STATEMENT: (Washington DC) – The Food and Drug Administration (@FDA) expects to publish a proposed rule this December requiring television and radio drug ads to carry full risk information inside the ad itself, according to HHS. The rule carries out President Trump's (@POTUS) September 2025 memorandum directing the Department of Health and Human Services (HHS) and the FDA to ensure "transparency and accuracy" in prescription drug advertising. The Independent Medical Alliance (IMA) says the change could reshape how Americans first learn about prescription drugs. "This rule will be a game changer," said IMA President and Chief Medical Officer Dr. Joseph Varon (@joevaron). "When the FDA loosened disclosure requirements in 1997 drug advertising took off, and America's reliance on prescription drugs grew right along with it." Before 1997, a broadcast drug ad had to include a summary of the drug's risks drawn from its label, which made most TV spots impractical. That August, the FDA issued guidance letting broadcast ads state only the major risks if they made "adequate provision" for viewers to find the rest elsewhere, such as a website or toll-free number. The new proposed rule would remove that option. The numbers since 1997: • Advertising: Drugmakers spent $791 million on consumer advertising in 1996, according to a 2002 New England Journal of Medicine analysis. By 2024 they spent more than $10 billion, according to the FDA. • Spending: @HHSGov says direct-to-consumer advertising drove 31 percent of the rise in U.S. drug spending since 1997. Total prescription drug spending reached $915 billion in 2025 and is projected to pass $1 trillion this year, according to the American Society of Health-System Pharmacists. • Use: The share of American adults who took a prescription drug in the past 30 days rose to nearly 6-in-10 by 2020, according to the National Institutes of Health (@NIH). • Seniors: Among adults 65 and older, the share taking five or more prescription drugs roughly tripled, from 13.8 percent in 1988-1994 to 41.9 percent in 2015-2018, CDC data show. • Volume: Pharmacies filled nearly 5 billion retail prescriptions in 2025, about 15 for every person in the country. "FDA opened the airwaves to nonstop drug advertising, and now we see patients asking for drugs by name," said Dr. Varon. "Putting the full safety facts back on the screen is a reasonable first step toward full transparency." The United States and New Zealand are the only two countries that allow drug companies to advertise prescription drugs directly to consumers.

Post attachment
Independent Medical Alliance avatar
⟳ Joseph Varon retweeted
Independent Medical Alliance@Honest_Medicine·Nov 13

Over 40 and Struggling to Read the Fine Print? Dr. Joseph Varon Explains Why IMA President and Chief Medical Officer Dr. Joseph Varon (@joevaron) joined @FoxNoticiasEnX to discuss presbyopia—the natural, age-related changes in vision that make it harder to focus on nearby objects. From reading glasses and prescription eye drops to simple everyday adjustments, Dr. Varon explains what happens to our eyes as we age, the options available, and why there's no reason to fear reaching for those reading glasses. Watch now - link below. 🔽

Post attachment
Leslie Manookian avatar
⟳ Joseph Varon retweeted
Leslie Manookian@LeslieManookian·Nov 13

Check out our important discussion on the future of holistic medicine - the true path to health and healing - at Brownstone's conference last weekend. @brownstoneinst @jeffreytucker @joevaron @DoctorCole @Honest_Medicine @theHFDF

Day 2 - 6th Annual Brownstone conf: They call it “alternative” medicine. It’s older than the drugs. @jeffreytucker, @DoctorCole , @LeslieManookian & @joevaron on oregano oil, homeopathy, Idaho Medical Freedom Act, & why telling the truth about health can still be illegal. ⚖️

38:04
Joseph Varon avatar
Joseph Varon@joevaron·Nov 11

On this Veterans Day, I want to express my deepest gratitude to every man and woman who has served our country. A special place in my heart belongs to my patients who proudly wore the uniform and, in many cases, sacrificed their health in service to our nation. As their physician, I have witnessed firsthand that some wounds never fully heal, and some sacrifices continue long after the uniform comes off. Your courage, resilience, and sacrifice will never be forgotten. Thank you for your service, your trust, and the privilege of caring for you. God bless our veterans, today and always.

Independent Medical Alliance avatar
⟳ Joseph Varon retweeted
Independent Medical Alliance@Honest_Medicine·Nov 10

Independent Medical Alliance Physicians Nationwide Prepare to Brief Incoming Members of Congress IMA doctors reaching out to newly elected members in their home states and districts with a practicing clinician’s view on transparency, patient choice, prior-authorization delays, and the prescription drug use epidemic. FULL STATEMENT: WASHINGTON (Nov. 9, 2026) – Physicians with the Independent Medical Alliance (IMA), a national coalition of more than 20,000 independent physicians, researchers and healthcare professionals, are preparing to connect in the coming weeks with newly elected members of Congress in their home states and districts, offering lawmakers of both parties a local, practicing physician they can call on for health policy. The IMA will brief incoming members on problems independent doctors see in their own practices: insurer prior authorization that delays treatment patients’ doctors have already ordered, rising prescription drug use, corporate consolidation pressures that are eliminating individual patient solutions and instead producing a ‘one-size-fits-all’ approach, and the right of patients and parents to complete information before treatment. “Every new member of Congress will be voting on policy that reaches into exam rooms in their district,” said Dr. Joseph Varon (@joevaron), IMA President and Chief Medical Officer. “They should be able to pick up the phone and talk to a doctor back home who answers to patients, not to a hospital system, an insurer or a political party. Our physicians will bring data and clinical experience, and they’ll bring them to any office that wants them, Republican or Democrat.” IMA physicians practice in all 50 states across dozens of specialties. The organization’s weekly Health Policy Brief, which draws on government and peer-reviewed data, reaches more than 9,000 policymakers, congressional staff and journalists nationwide, and is available to any congressional office on request. The IMA’s Journal of Independent Medicine (@JIndepMed) provides the nation’s foremost independent forum for doctors, researchers and other clinicians to discuss medical conditions, potential cures, and other aspects of healthcare.

Post attachment
Joseph Varon avatar
Joseph Varon@joevaron·Nov 9

I have been spending some time exploring OpenVSafe, and I must say that the amount of information available is extraordinary. We are talking about more than 10 million registrants, over 151 million health check-ins, and approximately 7.5 million free-text entries from the CDC's v-safe COVID-19 vaccine monitoring program. These are not simply numbers on a spreadsheet. Behind many of these entries are real people describing their experiences, symptoms, concerns, and sometimes very serious medical problems following vaccination. As a physician and researcher, I find this information incredibly valuable, especially because it lets us examine what patients reported in their own words. Of course, reporting a medical event after vaccination does not automatically establish causation, but we should not dismiss these reports without careful scientific investigation. Medicine advances when we ask difficult questions, examine the available evidence, and remain willing to challenge our assumptions. I encourage my colleagues, researchers, and anyone interested in medical transparency to explore this remarkable resource. This site contains an enormous amount of information that deserves thoughtful analysis. Patients deserve to be heard, and science deserves access to the data. My congratulations to everyone who worked to make this information accessible to the public. Transparency is not a threat to science. It is one of its greatest strengths.@Honest_Medicine openvsafe.org/

Joseph Varon avatar
Joseph Varon@joevaron·Nov 7

Joel Salatin delivered an extraordinary lecture tonight at the Brownstone gathering, reminding us of something that modern society seems to have forgotten. It really doesn't matter how much money you have accumulated in your 401(k) if, when a serious crisis strikes, you have no idea how to feed yourself or who you can depend on. True wealth is not measured exclusively in dollars, stocks, or retirement accounts. It is also measured in relationships, practical knowledge, self-reliance, and the ability to work together as a community. Do you know how to grow your own food? Do you know where your food comes from? Do you have neighbors and friends you can count on when things go wrong? We have become extraordinarily sophisticated technologically while becoming increasingly dependent on systems we barely understand and cannot control. Salatin reminded us that resilience begins with the land, the family, the community, and the relationships we cultivate long before a crisis arrives. Perhaps the greatest investment we can make in our future is not another contribution to a retirement account, but learning how to live, produce, cooperate, and care for one another. A remarkable lecture and a message worth taking seriously.@Honest_Medicine @brownstoneinst

Joseph Varon avatar
Joseph Varon@joevaron·Nov 7

What a privilege to have Joel Salatin sharing his wisdom with us tonight at the Brownstone Institute gathering in Chattanooga! Joel is not only a remarkable farmer, author, and speaker, but also a passionate defender of independence, individual responsibility, and the freedom to challenge conventional thinking. His message reminds us that the principles of freedom extend far beyond medicine. They reach into agriculture, food production, education, and virtually every aspect of our lives. As physicians, scientists, and scholars, we have much to learn from those who refuse to accept that established systems are necessarily the best systems. An inspiring evening surrounded by extraordinary minds, meaningful conversations, and people who still believe that independent thinking can change the world. This is what Brownstone is all about!@Honest_Medicine @brownstoneinst

Post attachment
Joseph Varon avatar
Joseph Varon@joevaron·Nov 6

There is always light at the end of the tunnel, even when the journey seems long and the obstacles appear overwhelming. Progress is made by those who refuse to surrender their principles, who continue asking difficult questions, and who believe that truth, courage, and intellectual freedom still matter. Here at Brownstone, surrounded by extraordinary scholars and independent thinkers, I am reminded that hope is not simply something we wait for. It is something we create through our work, our determination, and our willingness to stand together. The future is brighter when good minds and good hearts refuse to give up. Brownstone scholars at work!@Honest_Medicine @brownstoneinst

Independent Medical Alliance avatar
⟳ Joseph Varon retweeted
Independent Medical Alliance@Honest_Medicine·Nov 6

‘AI and Your Health: A Patient’s Search for Answers’ On this week’s show, IMA President and Chief Medical Officer Dr. Joseph Varon (@joevaron) was joined by Mikaël Wornoo, co-founder of TechWolf, to share his journey as a COVID-19 vaccine-injured patient searching for answers. They explored how patients can use AI to investigate complex health questions, navigate conflicting information, and have more informed conversations with their doctors, while also examining AI's limitations, particularly when researching vaccine injuries and other complex medical conditions. Watch now

48:14
Joseph Varon avatar
Joseph Varon@joevaron·Nov 5

There is something truly special about coming to Chattanooga for the annual Brownstone Institute Conference and Gala. Every year, I look forward to reconnecting with old friends, making new ones, and spending time with extraordinary individuals who share a passion for freedom, scientific integrity, intellectual honesty, and the courage to question established narratives. In a world where independent thinking is too often discouraged, Brownstone reminds us that respectful debate, open dialogue, and the pursuit of truth remain essential to a free society. For me, these gatherings are much more than conferences. They are opportunities to recharge intellectually, celebrate friendships, exchange ideas, and remember why we continue fighting for the principles we believe in. I am genuinely happy to be here once again, surrounded by people who understand that standing for what is right is not always easy, but it is always worth it. Thank you, Brownstone, for bringing us together and reminding us that courage and integrity still matter! @Honest_Medicine @brownstoneinst

Independent Medical Alliance avatar
⟳ Joseph Varon retweeted
Independent Medical Alliance@Honest_Medicine·Nov 4

TONIGHT! AI and Your Health: A Patient’s Search for Answers On tonight's show, IMA President and Chief Medical Officer Dr. Joseph Varon (@joevaron) will be joined by Mikaël Wornoo, co-founder of TechWolf, to share his journey as a COVID-19 vaccine-injured patient searching for answers. Together, they'll explore how patients can use AI to investigate complex health questions, navigate conflicting information, and have more informed conversations with their doctors, while also examining AI's limitations, particularly when researching vaccine injuries and other complex medical conditions. Wednesday, November 4th, at 7pm ET. Livestream here on X!

Post attachment